middle.news
CurveBeam AI Advances China JV and Clinical Programs Despite Regulatory Delays
7:50pm on Friday 15th of May, 2026 AEST
•
Healthcare
Read Story
CurveBeam AI Advances China JV and Clinical Programs Despite Regulatory Delays
7:50pm on Friday 15th of May, 2026 AEST
Key Points
Five device purchase orders including four HiRise™ units
FDA and NMPA clearances delayed to second half of 2026
A$4 million strategic investment received from WEGO Orthopaedics
Progress on robotic surgery system compatibility and THA protocol
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Curvebeam AI (ASX:CVB)
OPEN ARTICLE